Shanghai Pharmaceuticals Holding Co (HKSE:02607) Total Long-Term Liabilities : HK$10,462 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Shanghai Pharmaceuticals Holding Co's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was HK$10,462 Mil.

Shanghai Pharmaceuticals Holding Co Total Long-Term Liabilities Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Total Long-Term Liabilities Chart

Shanghai Pharmaceuticals Holding Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Long-Term Liabilities

Get a 7-Day Free Trial

7,482.38

15,360.91

10,543.36

10,144.32

12,202.08

Shanghai Pharmaceuticals Holding Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Long-Term Liabilities	Get a 7-Day Free Trial															10,925.89	10,768.81	12,168.44	12,202.08	10,462.43

Shanghai Pharmaceuticals Holding Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Shanghai Pharmaceuticals Holding Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pharmaceuticals Holding Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (HKSE:02607) » Definitions » Total Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

SHPMY:USA S1R:Germany 601607:China

Address

No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020

Website

https://www.sphchina.com

Shanghai Pharmaceuticals is the second-largest medical distributor in China by revenue. It is vertically integrated and provides healthcare services in research and development, manufacturing, distribution, and retail. As of 2024, medical distribution is the largest segment, accounting for 91.3% of total revenue. It also has coverage of 31 provinces and cities nationwide.

Executives

Shanghai Industrial Investment (holdings) Company Limited	2201 Interest of corporation controlled by you
Siic International Investment Company Limited	2101 Beneficial owner
New China Asset Management Co., Ltd.	2102 Investment manager
New China Life Insurance Company Ltd.	2101 Beneficial owner
Blackrock, Inc.	2201 Interest of corporation controlled by you
Citigroup Inc.	2201 Interest of corporation controlled by you
Lsv Asset Management	2102 Investment manager

Shanghai Pharmaceuticals Holding Co Headlines

No Headlines